Stay updated on IGN002 Clinical Trial in Refractory NHL
Sign up to get notified when there's something new on the IGN002 Clinical Trial in Refractory NHL page.

Latest updates to the IGN002 Clinical Trial in Refractory NHL page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new Locations section appears with California as the study site. The label 'California Locations' was removed and the HHS Vulnerability Disclosure link is gone; the revision is updated to v3.3.3.SummaryDifference0.3%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1 in the page footer; this is a minor metadata update with no impact on content or user experience. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1, indicating a maintenance update with no observable changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page no longer displays the banner about government funding delays and NIH operating status.SummaryDifference0.5%

- Check61 days agoChange DetectedThe new screenshot shows visual/UI layout changes without modifications to core study information such as eligibility criteria, endpoints, or patient data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check90 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

Stay in the know with updates to IGN002 Clinical Trial in Refractory NHL
Enter your email address, and we'll notify you when there's something new on the IGN002 Clinical Trial in Refractory NHL page.